Literature DB >> 1385420

Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA.

C Möller1, A Hansson, B Enberg, P E Lobie, G Norstedt.   

Abstract

The mechanism of growth hormone (GH) action was studied in Chinese hamster ovary (CHO) cells transfected with GH receptor cDNA. Cytosolic extracts from GH- or phorbol ester (12-O-tetradecanoyl 4 beta-phorbol 13-acetate)-treated cells, transfected with full-length GH receptor cDNA, had an enhanced ability to phosphorylate myelin basic protein. Myelin basic protein, a substrate for mitogen-activated protein (MAP) kinase, was maximally phosphorylated using extracts from cells treated with 50 nM bovine GH for 10 min. In addition, GH treatment resulted in an increased cell proliferation by 30-60%. GH and 12-O-tetradecanoyl 4 beta-phorbol 13-acetate cause tyrosine phosphorylation of two proteins with M(r) of 40,000 and 42,000 that are also recognized by MAP kinase antibodies. These proteins were identified as MAP kinases by analyzing phosphotyrosine immunoprecipitates on Western blots using MAP kinase antibodies. In addition, GH induces mitogenicity, as well as MAP kinase activation, in CHO cells expressing a receptor in which 184 amino acids had been deleted in the carboxyl-terminal part of the intracellular domain. No GH effects were seen in untransfected cells, in CHO cells expressing a truncated GH receptor containing only 5 of 349 amino acids in the intracellular domain, or in cells expressing the soluble GH-binding protein. In conclusion, our data show that GH treatment of CHO cells, reconstituted with GH receptors, initiates a phosphorylation cascade which includes MAP kinase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385420

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes.

Authors:  Vandana Singhal; Brian C Goh; Mary L Bouxsein; Marie-Claude Faugere; Douglas J DiGirolamo
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

2.  Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells.

Authors:  R Das; B K Vonderhaar
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  C/EBPβ mediates growth hormone-regulated expression of multiple target genes.

Authors:  Tracy X Cui; Grace Lin; Christopher R LaPensee; Anda-Alexandra Calinescu; Maanjot Rathore; Cale Streeter; Graciela Piwien-Pilipuk; Nathan Lanning; Hui Jin; Christin Carter-Su; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Endocrinol       Date:  2011-02-03

4.  Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor.

Authors:  Anna M Mazurkiewicz-Munoz; Lawrence S Argetsinger; Jean-Louis K Kouadio; Allan Stensballe; Ole N Jensen; Joel M Cline; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

5.  Growth hormone receptor C-terminal domains required for growth hormone-induced intracellular free Ca2+ oscillations and gene transcription.

Authors:  N Billestrup; P Bouchelouche; G Allevato; M Ilondo; J H Nielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction.

Authors:  L Goujon; G Allevato; G Simonin; L Paquereau; A Le Cam; J Clark; J H Nielsen; J Djiane; M C Postel-Vinay; M Edery
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

7.  Growth hormone (GH) induces tyrosine-phosphorylated proteins in mouse L cells that express recombinant GH receptors.

Authors:  X Wang; B Xu; S C Souza; J J Kopchick
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

8.  Identification of steroid-sensitive gene-1/Ccdc80 as a JAK2-binding protein.

Authors:  Erin E O'Leary; Anna M Mazurkiewicz-Muñoz; Lawrence S Argetsinger; Travis J Maures; Hung T Huynh; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2013-02-28

Review 9.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

Review 10.  Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling.

Authors:  Stuart J Frank
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-31       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.